Diagnostische und therapeutische Anwendung monoklonaler Antikörper in der Hämostaseologie

U. Scheefers-Borchel; G. Müller-Berghaus

doi:10.1055/s-0038-1655141

Hämostaseologie, Table of Contents

Hamostaseologie 1986; 06(02): 82-88
DOI: 10.1055/s-0038-1655141

Originalarbeiten

Schattauer GmbH

Diagnostische und therapeutische Anwendung monoklonaler Antikörper in der Hämostaseologie

Authors

U. Scheefers-Borchel

¹Klinische Forschungsgruppe für Blutgerinnung und Thrombose der Max-Planck-Gesellschaft am Klinikum der Universität Gießen
G. Müller-Berghaus

¹Klinische Forschungsgruppe für Blutgerinnung und Thrombose der Max-Planck-Gesellschaft am Klinikum der Universität Gießen

Abstract

Full Text

References

Literatur
1 Köhler G, Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7.
2 Littlefield J W. Selection of hybrids from matings of fibroblast in vitro and their presumed recombinants. Science 1964; 145: 709-14.
3 Small E J, Katzmann J A, Tracy R P, Ratnoff O D, Goldsmith Jr. G H, Everson B. A monoclonal antibody that inhibits activation of human Hageman factor (factor XII). Blood 1985; 65: 202-10.
4 Saito H, Ishihara T, Suzuki H, Watanabe T. Production and characterization of a murine monoclonal antibody against a heavy chain of Hageman factor (factor XII). Blood 1985; 65: 1263-8.
5 Sinha D, Koshy A, Seaman F S, Walsh P N. Functional characterization of human blood coagulation factor XI a using hybridoma antibodies. J Biol Chem 1985; 260: 10714-9.
6 Church W R, Mann K G. A simple purification of human factor X using a high affinity monoclonal antibody immunoadsorbant. Thromb Res 1985; 38: 417-27.
7 Goodall A H, Kemble G, O’Brien D P, Rawlings E, Rotblat F, Russell G C, Janossy G, Tuddenham E G. Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody. Blood 1982; 59: 664-70.
8 Thompson A R. Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients. Blood 1983; 62: 1027-34.
9 Smith K J, Ono K. Monoclonal antibodies to factor IX: characterization and use in immunoassays for factor IX. Thromb Res 1984; 33: 211-24.
10 Usharani P, Warn-Cramer B J, Kasper C K, Bajaj S P. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site. J Clin Invest 1985; 75: 76-83.
11 Yoshioka A, Giddings J C, Thomas J E, Fujimura Y, Bloom A L. Immunoassays of factor IX antigen using monoclonal antibodies. Br J Haematol 1985; 59: 265-75.
12 Wallmark A, Ljung R, Nilsson I M, Holmberg L, Hedner U, Lindvall M, Sjoegren H O. Polymorphism or normal factor IX detected by mouse monoclonal antibodies. Proc Natl Acad Sei USA 1985; 82: 3839-43.
13 Sola B, Avner P, Sultan Y, Jeanneau C, Maisonneuve P. Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities. Proc Natl Acad Sci USA 1982; 79: 183-7.
14 Bowie E J, Fass D N, Katzman J A. Functional studies of Willebrand factor using monoclonal antibodies. Blood 1983; 62: 146-51.
15 Sixma J J, Sakariassen K S, Stel H V, Houdijk W P, der Maur D W, Hamer R J, de Groot P G, van Mourik J A. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. J Clin Invest 1984; 74: 736-44.
16 Bradley L A, Franco E L, Reisner H M. Use of monoclonal antibodies in an enzyme immunoassay for factor VIII-related antigen. Clin Chem 1984; 30: 87-92.
17 Schullek J, Jordan J, Montgomery R R. Interaction of von Willebrand factor with human platelets in the plasma milieu. J Clin Invest 1984; 73: 421-8.
18 Meyer D, Zimmerman T S, Obert B, Edgington T S. Hybridoma antibodies to human von Willebrand factor. I. Characterization of seven clones. Br J Haematol 1984; 57: 597-608.
19 Meyer D, Baumgartner H R, Edgington T S. Hybridoma antibodies to human von Willebrand factor. II. Relative role of intramolecular loci in mediation of platelet adhesion to the subendothelium. Br J Haematol 1984; 57: 609-20.
20 Stel H V, Sakariassen K S, Schölte B J, Veerman E C, van der Kwast T H, de Groot P G, Sixma J J, van Mourik J A. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium. Blood 1984; 63: 1408-15.
21 Sultan Y, Avner P, Maisonneuve P, Arnaud D, Jeanneau C. An immunoradiometric assay for factor VIII related antigen (VIIIRAg) using two monoclonal antibodiescomparison with polyclonal rabbit antibodies for use in von Willebrand’s disease diagnosis. Thromb Haemost 1984; 52: 250-2.
22 Goodall A H, Jarvis J, Chand S, Rawlings E, O’Brien D P, McGraw A, Hutton R, Tuddenham E G. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII : vWF) using a monoclonal antibody that defines a functional epitope. Br J Haematol 1985; 59: 565-77.
23 Thomas J E, Peake I R, Giddings J C, Welch A N, Bloom A L. The application of a monoclonal antibody to factor VIII related antigen (VIIIRAg) in immunoradiometric assays for factor VIII. Thromb Haemost 1985; 53: 143-7.
24 Lamme S, Wallmark A, Holmberg L, Nilsson I M, Sjoegren H O. The use of monoclonal antibodies in measuring factor VIII/ von Willebrand factor. Scand J Clin Lab Invest 1985; 45: 17-26.
25 Goodall A H, Meyer D. Registry of monoclonal antibodies to factor VIII and von Willebrand factor. Thromb Haemost 1985; 54: 878-91.
26 Muller H P, van Tilburg N. H, Derks J, Klein-Breteler E, Bertina R M: A monoclonal antibody to VIII: C produced by a mouse hybridoma. Blood 1981; 58: 1000-6.
27 Fulcher C A, Roberts J R, Holland L Z, Zimmerman T S. Human factor-VIII procoagulant protein-monoclonal antibodies define precursor-product relationships and functional epitopes. J Clin Inv 1985; 76: 117-24.
28 Brown J E, Thuy L P, Carton C L, Hougie C. Studies on a monoclonal antibody to human factor VIII coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay. J Lab Clin Med 1983; 101: 793-805.
29 Rotblat F, Goodall A H, O’Brien D P, Rawlings E, Middleton S, Tuddenham E G. Monoclonal antibodies to human procoagulant factor VIII. J Lab Clin Med 1983; 101: 736-46.
30 Stel H V, Veerman E C, Huisman J G, Janssen M C, van Mourik J A. A rapid onestep immunoradiometric assay for factor VUI-procoagulant antigen utilizing monoclonal antibodies. Thromb Haemost 1983; 50: 860-3.
31 Stel H V, van der Kwast T H, Veerman E C. Detection of factor VUI/coagulant antigen in human liver tissue. Nature 1983; 303: 530-2.
32 Fulcher C A, Roberts J R, Holland L Z, Zimmerman T S. Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationship and functional epitopes. J Clin Invest 1985; 76: 117-24.
33 Broze G J, Hickmann S, Miletich J P. Monoclonal anti-human factor-VII antibodies-detection in plasma of 2nd protein antigenically and genetically related to factor-VII. J Clin Invest 1985; 76: 937-46.
34 Foster W B, Tucker M M, Katzman J A, Mann K G. Monoclonal antibodies selective for activated Factor V. Immunochemical probes for structural transitions occurring during the thrombin-catalyzed activation of the procofactor. J Biol Chem 1983; 258: 5608-13.
35 Foster W B, Tucker M M, Katzman J A, Miller R S, Nesheim M E, Mann K G. Monoclonal antibodies to human coagulation factor V and factor Va. Blood 1983; 61: 1060-7.
36 Lewis R M, Furie B C, Furie B. Conformation-specific monoclonal antibodies directed against the calcium-stabilized structure of human prothrombin. Biochemistry 1983; 22: 948-54.
37 Carson S D, Bach R, Carson S M. Monoclonal antibodies against bovine tissue factor, which block interaction with factor VII_a . Blood 1985; 66: 152-6.
38 Owens J, Lewis R M, Cantor A, Furie B C, Furie B. Monoclonal antibodies against human abnormal (des-gamma-carboxy) prothrombin specific for the calcium-free conformer of prothrombin. J Biol Chem 1984; 259: 13800-5.
39 Dawes J, James K, Micklem L R, Pepper D S, Prowse C V. Monoclonal antibodies directed against human alpha-thrombin and the thrombin-antithrombin III complex. Thromb Res 1984; 36: 397-409.
40 Wilner G D, Mudd M S, Hsieh K, Thomas D W. Monoclonal antibodies to fibrinogen : modulation of determinants expressed in fibrinogen by gamma-chain cross-linking. Biochemistry 1982; 21: 2687-92.
41 Sola B, Avner P R, Zilbert M T, Connan F, Levy D. Isolation and characterization öf a monoclonal antibody specific for fibrinogen and fibrin of human origin. Thromb Res 1983; 29: 643-53.
42 Ehrlich P H, Sobel J H, Moustafa Z A, Canfield R E. Monoclonal antibodies to alpha-chain regions of human fibrinogen that participate in polymer formation. Biochemistry 1983; 22: 4184-92.
43 Francis S E, Joshua D E, Exner T, Kronenberg H. Some studies with a monoclonal antibody directed against human fibrinogen. Am J Hematol 1985; 18: 111-9.
44 Koppert P W, Huijsmans C M, Nieuwenhuizen W. A monoclonal antibody, specific for human fibrinogen, fibrinopeptide Acontaining fragments and not reacting with free fibrinopeptide A. Blood 1985; 66: 503-7.
45 Kudryk B, Rohaza A, Ahadi M, Chin J, Wiebe M E. Specificity of a monoclonal antibody for the NH₂-terminal region of fibrin. Mol Immunol 1984; 21: 89-94.
46 Hui K Y, Haber E, Matsueda G R. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 1983; 222: 1129-32.
47 Scheefers-Borchel U, Müller-Berghaus G, Fuhge P, Eberle R, Heimburger N. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic hexapeptide. Proc Natl Acad Sci USA 1985; 82: 7091-5.
48 Kudryk B, Rohoza A, Ahadi M, Chin J, Wiebe M E. A monoclonal antibody with ability to distinguish between NH₂-terminal fragments derived from fibrinogen and fibrin. Mol Immunol 1983; 20: 1191-200.
49 Soria J, Soria C, Boucheix C, Mirshahi M, Perrot J Y, Bernadou A, Samama M, Rosenfeld C. Monoclonal antibodies that react preferentially with fibrinogen degradation products or with cross-linked fibrin split products. Ann NY Acad Sei 1983; 409: 665-6.
50 Suzuki K, Matsuda Y, Kusumoto H, Nishioka J, Terada M, Yamashita T, Hashimoto S. Monoclonal antibodies to human protein C: Effects on the biological activity of activated protein C and the thrombin-catalyzed activation of protein C. J Biochem 1985; 97: 127-38.
51 Suzuki K, Moriguchi A, Nagayoshi A, Mutoh S, Katsuki S, Hashimoto S. Enzyme immunoassay of human protein C by using monoclonal antibodies. Thromb Res 1985; 38: 611-21.
52 Mammen E F. Protein C and S. Hämostaseologie 1984; 04: 138-47.
53 Matsuo O, Tanbara Y, Okada K, Bando H, Nagoya T. Monoclonal antibody to human tissue plasminogen activator. Thromb Res 1984; 36: 517-26.
54 Schleef R R, Sinha M, Loskutoff D J. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator. Thromb Haemost 1985; 53: 170-5.
55 MacGregor I R, Micklem L R, James K, Pepper D S. Characterization of epitopes on human tissue plasminogen activator recognized by a group of monoclonal antibodies. Thromb Haemostas 1985; 53: 45-50.
56 Soria J, Soria C, Mirshahi M, Samama M M. Markers of fibrinogen derivatives used in clinical investigation. Semin Thromb Hemost 1985; 11: 129-32.
57 Gaffney P J, Jesperson J, Miiller-Berghaus G. Monoclonal antibodies against fibrinogen, fibrin and their fragments. Thromb Haemost 1985; 54: 733-4.
58 Coller B S. Report of the working party on hybridoma-derived monoclonal antibodies to platelets. Thromb Haemost 1984; 51: 169-73.
59 Gralnick H R, Williams S B, Coller B S. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein II b/ III a complex when platelets are stimulated with thrombin. Blood 1984; 64: 797-800.
60 Marguerie G A, Plow E F, Edgington T S. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-63.
61 Phillips D R, Agin P P. Platelet membrane defects in Glanzmann’s thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977; 60: 535-45.
62 Heinrich D, Scharf T, Santoso S, Clemetson K J, Mueller-Eckhardt C. Monoclonal antibodies against human platelet membrane glycoproteins IIb-IIIa. II. Different effects on platelet function. Thromb Res 1985; 38: 547-59.
63 Coller B S. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein II b/ IIIa complex. J Clin Invest 1985; 76: 101-8.
64 Shattil S J, Hoxie J A, Cunningham M, Brass L F. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-14.
65 Plow E F, McEver R P, Coller B S, Woods Jr. V L, Marguerie G A, Ginsberg M H. Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets. Blood 1985; 66: 724-7.
66 Peerschke E I. Ca²⁺ mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation. J Lab Clin Med 1985; 106: 111-22.
67 Mitchell M S, Oettgen H F. Hybridomas in cancer diagnosis and treatment. In: Progress in Cancer Research and Therapy. Raven Press; New York: 1982: 21.
68 Olsson L, Kaplan H S. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci USA 1980; 77: 5429.
69 Boulianne G L, Hozumi N, Shulmann M J. Production of functional chimaeric mouse/ human antibody. Nature 1984; 312: 643-6.
70 Harris W H, Salzman E W, Athanasoulis C, Waltman A C, Baum S, DeSanctis R W, Potsaid M, Sise H. Comparison of ¹²⁵Ifibrinogen count scanning with phlebography for detection of venous thrombi after elective hip surgery. N Engl J Med 1975; 292: 665-73.
71 Prowes W J, Siegel B J. Thrombus imaging with Indium-111 platelets. Sem Thromb Hemostas 1983; 09: 115-31.
72 Oster Z H, Srivastava S C, Som P, Meinken G E, Scudder L E, Yamamoto K, Atkins H L, Brill A B, Coller B S. Thrombus radioimmunoscintigraphy: An approach using monoclonal antiplatelet antibody. Proc Natl Acad Sci USA 1985; 82: 3465-8.
73 Bode C, Matsueda G R, Hui K Y, Haber E. Antibody-directed urokinase: A specific fibrinolytic agent. Science 1985; 229: 765-7.
74 Van Mourik J A, Leeksma O C, Reinders J H, de Groot P G, Zandbergen-Spaargaren J. Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa. J Biol Chem 1985; 260: 11300-6.
75 Katzman J A, Nesheim M E, Hibbard L S, Mann K G. Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci USA 1981; 78: 162-6.